KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Gross Profit (2016 - 2025)

Historic Gross Profit for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $3.7 billion.

  • Boston Scientific's Gross Profit rose 1886.91% to $3.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 billion, marking a year-over-year increase of 2058.31%. This contributed to the annual value of $13.9 billion for FY2025, which is 2057.44% up from last year.
  • Per Boston Scientific's latest filing, its Gross Profit stood at $3.7 billion for Q4 2025, which was up 1886.91% from $3.5 billion recorded in Q3 2025.
  • Boston Scientific's 5-year Gross Profit high stood at $3.7 billion for Q4 2025, and its period low was $1.9 billion during Q1 2021.
  • Its 5-year average for Gross Profit is $2.6 billion, with a median of $2.5 billion in 2023.
  • Per our database at Business Quant, Boston Scientific's Gross Profit skyrocketed by 7590.76% in 2021 and then skyrocketed by 357.31% in 2022.
  • Over the past 5 years, Boston Scientific's Gross Profit (Quarter) stood at $2.2 billion in 2021, then rose by 3.57% to $2.2 billion in 2022, then rose by 15.55% to $2.6 billion in 2023, then increased by 20.01% to $3.1 billion in 2024, then rose by 18.87% to $3.7 billion in 2025.
  • Its last three reported values are $3.7 billion in Q4 2025, $3.5 billion for Q3 2025, and $3.4 billion during Q2 2025.